Ads
    Related paper
  1. Are Cladribine and Rituximab Enough for the Treatment of Relapsed Hairy Cell Leukemia?
  2. Cost-Effectiveness of Idelalisib-Rituximab for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia
  3. The Therapy of Hairy Cell Leukemia: The State of Art
  4. Hairy cell leukemia: a rare case report
  5. HAIRY CELL LEUKEMIA IN A PATIENT OF HEAD AND NECK CANCER -A RARE CASE SCENARIO
  6. CLINICAL EFFICIENCY OF COMBINATION OF BENDAMUSTINE + RITUXIMAB IN FIRST LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA AND PATIENTS WITH RECURRENT DISEASE
  7. Cladribine an Alternative for Midostaurine in FLT3 Positive Acute Myeloid Leukemia
  8. Immunoblastic morphology as a possible prognostic indicator for the outcome of the patients with diffuse large B cell lymphoma in era of the rituximab based treatment: single centre experience
  9. Bilateral parotid gland enlargement as a presenting manifestation of relapsed pediatric acute myeloid leukemia
  10. DENDRITIC CELL VACCINATION AS POST-REMISSION TREATMENT TO PREVENT OR DELAY RELAPSE IN ACUTE MYELOID LEUKEMIA